In a double-blind, placebo-controlled clinical trial (power of 80% to detect a 30% reduction in morphine consumption, P<0.05), we have determined that the administration of two doses of intravenous ketoprofen 100 mg, one at the end of surgery and the second 12 hours postoperatively, was associated with a significant reduction in morphine consumption at eight (P=0.028), 12 (P=0.013) and 24 hours (P=0.013) but not four hours (P=0.065) postoperatively, as compared to placebo, when assessed by patient-controlled analgesia. There was no difference between the groups in pain scores or in the incidence of nausea and vomiting. One patient in the placebo group suffered from excessive sedation while one patient from the ketoprofen group suffered from transient oliguric renal failure. There were no other adverse effects. The results of this study show that ketoprofen does provide a morphinesparing effect in the management of postoperative pain after abdominal surgery.
Non-steroidal anti-inflammatory drugs (NSAID) reduce the opioid requirements of patients after surgery 1, 2 . The addition of NSAID has also been reported to improve the quality of analgesia as well as reduce the need for opioids and thus reduce opioid-related side-effects, in particular respiratory depression 3, 4 .
Ketoprofen, a phenylpropionic acid derivative, is a NSAID and its anti-inflammatory effect is achieved via inhibition of the enzyme cyclo-oxygenase, thus reducing prostaglandin synthesis 5 . The analgesic effect of ketoprofen is also thought to have a central component. It has been shown to inhibit spinal cord nociceptor reflex activity 6 and also to reduce wind-up or central sensitization in the spinal cord 7 .
Patient-controlled analgesia (PCA) is an effective form of analgesia where the patient is in control of his/her own pain relief 8 . However there have been reported side-effects associated with the use of PCA such as respiratory depression 9 as well as nausea and vomiting 10 . Ketoprofen reduces morphine-induced respiratory depression in human volunteers, and although the mechanism involved remains unclear, a centrally mediated effect has been postulated 11 . Ketoprofen is effective in controlling postoperative pain after orthopaedic surgery, in particular after knee or hip surgery 12 . Other NSAIDs, ketorolac tromethamine and diclofenac sodium, have been shown to provide a morphine-sparing effect after abdominal surgery 3, 4 .
The aim of our study was to assess the efficacy of intravenous ketoprofen in reducing morphine requirements of patients after abdominal surgery.
METHODS AND MATERIALS
Approval was obtained from the hospital clinical research committee and ethics committee before commencing the study. Patients aged 18 to 60 years and weighing 40 to 95 kg scheduled to undergo elective bowel surgery by the same team of surgeons, which involved a lower midline skin incision, were considered eligible for inclusion in this study. Exclusion criteria included patients with a history of previous allergy to ketoprofen, aspirin and other NSAIDs, peptic ulcer disease, significant respiratory, renal or liver disease, history of depression, dementia or substance abuse, pregnant or lactating patients and patients with coagulopathies. At preoperative assessment, written informed consent was taken from all patients and they were instructed on the use of a PCA and a five-point verbal numerical pain scale (see below).
All patients received midazolam 7.5 mg orally as premedication. Anaesthesia was induced with sodium thiopentone 5 mg/kg and maintained with oxygen, nitrous oxide and isoflurane, with increments of vecuronium or atracurium to provide muscle relaxation. Intraoperative analgesia was confined to intravenous fentanyl 2 µg/kg at induction and 1 µg/kg per hour of surgery. All patients had their skin incision infiltrated with 20 ml of 0.25% plain bupivacaine at the end of surgery.
The patients were randomly allocated to receive two doses of either a placebo (10 ml of normal saline) or intravenous ketoprofen (100 mg diluted in 10 ml of normal saline), given as a bolus over two minutes. Randomization was done using the random permuted block method and this was transferred to a series of 40 opaque, sealed envelopes containing either ketoprofen or saline labels. The first dose was given half an hour before the end of surgery and the second 12 hours later. An anaesthetist who was not involved in the study follow-up gave the doses. In the recovery room, intravenous morphine was titrated until the patient was comfortable (pain score of 0 to 1) by the same blinded anaesthetist, and then an Abbott Lifecare 4200 patient-controlled analgesia system (PCA) was set up for the patient. The PCA device was programmed to deliver incremental doses of 1 mg of morphine on patient demand with a lockout interval of five minutes. All patients were kept in the recovery room for 30 to 45 minutes before being discharged to the ward.
In the ward, the blood pressure, respiratory rate, pulse rate, urine output and PCA pump delivery rate of the patients were checked hourly for the first four hours and then four hourly by the nursing staff. In addition to this, all patients were assessed by an independent observer, who was unaware of the group to which the patient had been allocated to, at 4, 8, 12 and 24 hours postoperatively. The assessments were made using a five-point verbal numerical pain scale (0=no pain, 1=slight pain, 2=tolerable pain, 3=bad pain, 4=worst pain imaginable); sedation score (0=none, 1=occasionally drowsy, 2=frequently drowsy, easily arousable, 3=difficult to arouse, S=sleeping, easy to arouse); frequency of anti-emetic administration and the presence of any other adverse effects which were noted down.
The power of the study was predicted using a onetailed t-test, assuming ketoprofen to reduce morphine requirements by 30%. A figure of 30% was taken because similar studies with other NSAIDs have shown a 30% reduction in morphine consumption when a combination of morphine and a NSAID is used postoperatively 3, 4 . Using a sample size of 20 in each group, this gave the study an 80% power to detect such a difference at a P<0.05 level of significance. Demographic data and morphine consumption were analysed using the unpaired Student's t-test and multivariate ANOVA (after having tested the data for normality). The Mann-Whitney U test was used to analyse ordinal data and this included pain scores. A significance level of P<0.05 was employed.
RESULTS
Forty patients were included in the study. There were no significant differences between the groups in age, gender, weight or the duration of operation (Table 1) . One patient was removed from the placebo group because she developed excessive sedation (sedation score of 2 persistently) and her PCA dose had to be reduced to 0.5 mg, six hours postoperatively.
The mean (95% CI) morphine consumption in the Recovery Room was 5.31 (1.23) mg in the placebo group compared to 2.38 (0.84) mg in the ketoprofen group. This difference was statistically significant (P=0.003). Patients from both groups spent the same amount of time in the Recovery Room. The cumulative morphine consumption at 4, 8, 12 and 24 hours postoperatively was always less in the ketoprofen group. Although the reduction in morphine consumption at four hours postoperatively was not statistically significant, it reached statistical significance at 8, 12 and 24 hours postoperatively (Figure 1 ). There was no significant difference in pain scores at rest in both groups, indicating that there was no difference in analgesic efficacy between the two groups ( Table 2) .
One patient in the placebo group had excessive drowsiness and her PCA morphine bolus dose was reduced to 0.5 mg six hours postoperatively. There were six requirements for intravenous metoclopramide to treat nausea and vomiting in the placebo group while there were four requirements in the ketoprofen group in the first 24 hours postoperatively.
One patient in the ketoprofen group developed transient oliguric renal failure.
No patient complained of any gastrointestinal discomfort or had evidence of gastrointestinal irritation in the first 24 hours postoperatively and no patient in either group had any evidence of respiratory depression (i.e., respiratory rate of less than 8 at any time).
DISCUSSION
This study showed that intravenous ketoprofen reduced postoperative morphine consumption by over one third within the first 24 hours. The cumulative morphine consumption at 4, 8, 12 and 24 hours postoperatively was less for the ketoprofen group.
This difference reached statistical significance at 8, 12 and 24 hours postoperatively.
The morphine-sparing effect of ketoprofen was found to be comparable to studies done with other NSAIDs 3, 4 . Both Gillies et al and Hodsman et al found that ketorolac trimethamine and diclofenac sodium respectively, reduced the morphine requirements by one third.
Patients in the ketoprofen group needed a significantly smaller dose of morphine in the recovery room when morphine was titrated to comfort. This could be attributed to the injection of intravenous ketoprofen given 30 minutes before the end of surgery as ketoprofen given as an intravenous bolus has been shown to suppress pain within 5 to 30 minutes of its administration 13 .
All the patients in both groups had adequate analgesia as evident by them having median pain scores at rest of 1 to 2 at 4, 8, 12 and 24 hours postoperatively. Other studies have shown that the addition of a NSAID together with an opioid-based PCA system did result in lower pain scores 3, 4 . Our study however, as with Owen et al 14 , did not find any difference in pain scores. This could be due to the fact that the placebo group using the PCA system was able to titrate more morphine to compensate for the lack of ketoprofen effect and thus reach the same analgesic level. There were six requirements for metoclopramide in the placebo group compared to four in the ketoprofen group in the first 24 hours postoperatively. One patient in the placebo group had excessive sedation compared to none in the ketoprofen group. However, although opioid-related side-effects seemed to occur more in the placebo group, these differences were not statistically significant.
One patient from the ketoprofen group developed transient oliguric renal failure. On review of her anaesthetic chart, a period of intraoperative hypotension was noted. She was also found to be hypovolaemic on insertion of a central venous line. After rehydration, her blood urea and creatinine levels, which had doubled from her preoperative values, as well as her urine output, returned to normal.
Renal blood flow is partly dependent on prostaglandins, especially during stressful periods where the renin-angiotensin system is activated 15, 16 . In fact surgery itself is a physiologically stressful period and is associated with reduction in renal blood flow. Risk factors for the development of renal failure for a patient on NSAIDs are advanced age, cirrhosis, heart failure, shock or volume depletion, use of nephrotoxic drugs and evidence of pre-existing renal impairment 15, 16 . Among the risk factors present for this patient were her age (60 years), the intraoperative hypotensive episode and her postoperative hypovolaemic state. The use of ketoprofen in this situation probably contributed significantly to the development of oliguric renal failure. Thus it remains prudent to use ketoprofen cautiously in patients with these risk factors.
It is now known that there are two structurally distinct forms of the enzyme cyclo-oxygenase (COX-1 and COX-2). COX-1 is a constitutive member of normal cells which is responsible for prostaglandin synthesis for physiological functions. These include maintenance of normal renal perfusion, protection of gastrointestinal mucosa and platelet aggregation. COX-2 is an inducible enzyme produced by inflammatory cells. The anti-inflammatory and analgesic actions of NSAIDs are thought to be due to the inhibition of COX-2 while the unwanted side-effects are due to the inhibition of COX-1. Thus ketoprofen which is a non-selective inhibitor of COX would tend to have more NSAID-related side-effects compared to other NSAIDs which inhibit COX-2 more selectively 17 .
CONCLUSION
The results of this study show that intermittent intravenous injection of ketoprofen does provide a morphine-sparing effect in the management of postoperative pain after abdominal surgery. This morphine-sparing effect is comparable to that obtained with other NSAIDs. However the selection of patients for ketoprofen, as for any other NSAID, should be done with caution. Risk factors for adverse effects of NSAID including those for renal failure as mentioned above, should be identified and considered before administration of the drug.
